Who invested in eXelate?
eXelate's investors include Carmel Ventures, Menlo Ventures, Trident Capital and NewSpring.

United States · Series C startup
3 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow eXelate and see its new rounds in your feed.Start following
Funding summaryUpdated 31 Oct 2026
$32Mraised across 3 rounds since 2007, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by finance.yahoo.comSEC filing: $12M sold, first sale Sept 2012
From the SEC filings it signed: 4 on the team.
On the board, as filediEvangelos T. SimoudisGlenn T. RiegerMark T. SiegelMartin T. NisenholtzMeir ZoharShlomo T. Dovrat
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
From historical deal records. Wrong? Tell us.
eXelate's investors include Carmel Ventures, Menlo Ventures, Trident Capital and NewSpring.
eXelate has raised $32M across 3 rounds since 2007.
eXelate's most recent round was a Series C of $12M in Sept 2012.
eXelate's largest round on record is $16M (Series B), in Aug 2010.
eXelate's first round on record, in Oct 2007, was backed by Carmel Ventures.
eXelate's latest named round is a Series C, in Sept 2012.
eXelate is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.